Skip to content

LBRX LBRX Change in Lease Liabilities

Change in Lease Liabilities at other companies

MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$211K-14.7%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$123K+35.3%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$535K-18.9%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$349K-13.7%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
-$101K+66.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$1.85M-26.0%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+163%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's change in lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's change in lease liabilities?
LBRX (LBRX) reported change in lease liabilities of -$99K in Q1 2026.
How has LBRX's change in lease liabilities changed year-over-year?
LBRX's change in lease liabilities decreased by 5050.0% year-over-year, from $2K to -$99K.
What does change in lease liabilities mean?
Cash payments for operating leases reducing the lease liability, partially offset by new lease commencements.